Apyx Medical Inc Cash Flow-to-Debt Ratio
Apyx Medical Inc cash flow-to-debt ratio. Apyx Medical Inc (APYX) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2026, meaning its operating cash flow of $-3.49 Million could theoretically repay 0% of its total liabilities ($49.98 Million) in one year. Check Apyx Medical Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Apyx Medical Inc (1995–2025)
Cash flow-to-debt ratio of Apyx Medical Inc from 1995 to 2025. Historical debt coverage capacity for Apyx Medical Inc across 31 annual periods. Check how aggressively does Apyx Medical Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Apyx Medical Inc Cash Flow-to-Debt Ratio by Year (1995–2025)
Apyx Medical Inc cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Apyx Medical Inc. For the full cash flow conversion analysis, see APYX cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.15x | $-8.00 Million | $52.01 Million | ▲ +56.9% |
| 2024 | -0.36x | $-18.05 Million | $50.51 Million | ▼ -256.1% |
| 2023 | -0.10x | $-5.25 Million | $52.32 Million | ▲ +93.1% |
| 2022 | -1.45x | $-20.28 Million | $13.98 Million | ▼ -104.2% |
| 2021 | -0.71x | $-10.45 Million | $14.71 Million | ▲ +54.7% |
| 2020 | -1.57x | $-16.07 Million | $10.25 Million | ▼ -13.8% |
| 2019 | -1.38x | $-18.48 Million | $13.42 Million | ▲ +48.6% |
| 2018 | -2.68x | $-21.01 Million | $7.84 Million | ▼ -547.8% |
| 2017 | -0.41x | $-3.70 Million | $8.96 Million | ▼ -29.6% |
| 2016 | -0.32x | $-2.84 Million | $8.89 Million | ▲ +55.6% |
| 2015 | -0.72x | $-5.79 Million | $8.04 Million | ▼ -3373.8% |
| 2014 | -0.02x | $-417.00K | $20.14 Million | ▲ +90.3% |
| 2013 | -0.21x | $-2.54 Million | $11.85 Million | ▼ -786.1% |
| 2012 | 0.03x | $165.00K | $5.29 Million | ▼ -89.9% |
| 2011 | 0.31x | $1.90 Million | $6.12 Million | ▲ +429.6% |
| 2010 | -0.09x | $-566.00K | $6.02 Million | ▼ -514.8% |
| 2009 | -0.02x | $-98.33K | $6.43 Million | ▼ -114.4% |
| 2008 | 0.11x | $742.83K | $6.99 Million | ▼ -89.4% |
| 2007 | 1.01x | $2.04 Million | $2.03 Million | ▼ -15.6% |
| 2006 | 1.19x | $2.99 Million | $2.51 Million | ▲ +1249.8% |
| 2005 | -0.10x | $-189.62K | $1.83 Million | ▼ -108.9% |
| 2004 | 1.16x | $2.04 Million | $1.76 Million | ▲ +400.4% |
| 2003 | 0.23x | $413.52K | $1.78 Million | ▲ +529.6% |
| 2002 | 0.04x | $73.98K | $2.01 Million | ▼ -93.8% |
| 2001 | 0.60x | $940.78K | $1.58 Million | ▲ +37.8% |
| 2000 | 0.43x | $657.50K | $1.52 Million | ▲ +8.4% |
| 1999 | 0.40x | $530.72K | $1.33 Million | ▲ +4006.4% |
| 1998 | -0.01x | $-14.01K | $1.37 Million | ▲ +83.3% |
| 1997 | -0.06x | $-98.79K | $1.61 Million | ▼ -127.1% |
| 1996 | 0.23x | $425.30K | $1.88 Million | ▲ +5674.6% |
| 1995 | 0.00x | $12.50K | $3.19 Million | — |